Related Experiment Videos
Recent insights into the structure, function and biology of cPLA2
1Lilly Research Laboratories, Indianapolis, Indiana 46285, USA.
Agents and Actions. Supplements
|January 1, 1995
Summary
Cytosolic phospholipase A2 (cPLA2) is a key enzyme in inflammatory and allergic reactions. Inhibiting cPLA2 may offer a new therapeutic strategy for treating inflammatory diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- The 85-kDa cytosolic phospholipase A2 (cPLA2) is widely expressed in cells and tissues.
- cPLA2 hydrolyzes cellular phospholipids, generating precursors for inflammatory mediators like eicosanoids and platelet-activating factor (PAF).
Purpose of the Study:
- To review the role of cPLA2 in inflammatory and allergic responses.
- To explore the potential of cPLA2 inhibitors as therapeutic agents for inflammatory diseases.
Main Methods:
- Literature review of recent studies on cPLA2.
- Analysis of cPLA2's involvement in receptor-mediated inflammatory signaling pathways.
Main Results:
- cPLA2 activation by agonists, growth factors, and cytokines is crucial for inflammatory mediator biosynthesis.
- Emerging evidence indicates cPLA2 functions as a receptor-regulated enzyme in inflammation.
Conclusions:
- cPLA2 plays a significant role in mediating inflammatory and allergic reactions.
- Targeting cPLA2 with inhibitors presents a promising therapeutic avenue for inflammatory conditions.